Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
Saved in:
| Title: | Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. |
|---|---|
| Authors: | Tutrone R; Chesapeake Urology, Towson, MD, USA. Electronic address: rtutrone@uniteduro.com., Saad F; University of Montreal Hospital Centre, Montreal, QC, Canada., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Tombal B; Institut de Recherche Clinique, Université Catholique de Louvain, Brussels, Belgium., Bailen JL; First Urology, Jeffersonville, IN, USA., Cookson MS; Department of Urology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Saltzstein DR; Urology San Antonio, San Antonio, TX, USA., Hanson S; Pfizer, Inc., New York, NY, USA., Brown B; Myovant Sciences, Inc., Brisbane, CA, USA., Lu S; Myovant Sciences, Inc., Brisbane, CA, USA., Fallick M; Myovant Sciences, Inc., Brisbane, CA, USA., Shore ND; Carolina Urologic Research Center and GenesisCare USA, Myrtle Beach, SC, USA. |
| Source: | European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 906-913. Date of Electronic Publication: 2023 Dec 23. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
